Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioventus Inc Cl A (NQ: BVS )

11.10 -0.58 (-4.97%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bioventus Inc Cl A

< Previous 1 2 3 Next >
EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Bioventus Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BVS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Bronstein, Gewirtz & Grossman, LLC Notifies Bioventus Inc. (BVS) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bioventus, ESS, and IBM and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
EQUITY ALERT: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Bioventus Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BVS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bioventus Inc. (BVS)
From Glancy Prongay & Murray LLP
Via Business Wire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bioventus Inc. (BVS)
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Bioventus Inc. (BVS) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Bioventus Inc. (BVS) Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Lowey Dannenberg Notifies Bioventus Inc. (NASDAQ: BVS) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline
From Lowey Dannenberg, P.C.
Via GlobeNewswire
EQUITY ALERT: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Bioventus Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – BVS
From The Rosen Law Firm, P.A.
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Bioventus Inc. (BVS) Investors
From Law Offices of Howard G. Smith
Via Business Wire
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Bioventus Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf Bioventus Inc. (BVS) Investors
From Kirby McInerney LLP
Via Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Bioventus Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Bioventus Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Bioventus, Inc.
Via GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Bioventus Inc. (BVS) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
NASDAQ:BVS Investor Alert: Investigation over Possible Securities Laws Violations by Bioventus Inc.
San Diego, CA -- (SBWIRE) -- 11/29/2022 -- An investigation was announced for investors of Bioventus Inc. (NASDAQ:BVS) shares over potential securities laws violations by Bioventus Inc. 
Via SBWire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Bioventus Inc. (BVS) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Bioventus Inc. (BVS) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Bioventus Inc. Investors to Inquire About Securities Class Action Investigation – BVS
From The Rosen Law Firm, P.A.
Via Business Wire
Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022
From Bioventus, Inc.
Via GlobeNewswire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Bioventus Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Bioventus Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago
Full Launch of BoneScalpel® Access™ at NASS 
From Bioventus, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.